LAURUSLABS

Laurus Labs Share Price

₹617.70 +2.9 (0.47%)

27 Mar, 2025 16:06

SIP TrendupStart SIP in LAURUSLABS

Start SIP

Performance

  • Low
  • ₹606
  • High
  • ₹621
  • 52 Week Low
  • ₹385
  • 52 Week High
  • ₹646
  • Open Price₹615
  • Previous Close₹615
  • Volume1,293,605

Investment Returns

  • Over 1 Month + 12.39%
  • Over 3 Month + 8.36%
  • Over 6 Month + 33.48%
  • Over 1 Year + 55.49%
SIP Lightning

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 166.3
  • PEG Ratio
  • 25.3
  • Market Cap Cr
  • 33,310
  • P/B Ratio
  • 8.1
  • Average True Range
  • 19.96
  • EPS
  • 3.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 6.92
  • RSI
  • 60.99
  • MFI
  • 68.67

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹617.70
+ 2.9 (0.47%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹588.74
  • 50 Day
  • ₹577.20
  • 100 Day
  • ₹558.60
  • 200 Day
  • ₹523.01

Resistance and Support

614.9 Pivot Speed
  • R3 628.20
  • R2 623.80
  • R1 619.30
  • S1 610.40
  • S2 606.00
  • S3 601.50

What's your outlook on Laurus Labs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 5,273.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 5% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 20% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 4% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results & Interim Dividend
2024-07-25 Quarterly Results
2024-04-25 Audited Results & Interim Dividend
2024-01-24 Quarterly Results
Date Purpose Remarks
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-05-10 INTERIM Rs.1.20 per share(60%)Interim Dividend
2022-11-04 INTERIM Rs.0.80 per share(40%)Interim Dividend
View More
Date Purpose Remarks
2020-09-30 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.62%
7.62%
4.08%
25.56%
0%
22.72%
12.4%

About Laurus Labs

  • NSE Symbol
  • LAURUSLABS
  • BSE Symbol
  • 540222
  • ISIN
  • INE947Q01028

Similar Stocks to Laurus Labs

Laurus Labs FAQs

Laurus Labs share price is ₹617 As on 27 March, 2025 | 15:52

The Market Cap of Laurus Labs is ₹33309.6 Cr As on 27 March, 2025 | 15:52

The P/E ratio of Laurus Labs is 166.3 As on 27 March, 2025 | 15:52

The PB ratio of Laurus Labs is 8.1 As on 27 March, 2025 | 15:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23